PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs UTHR |
|---|---|---|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 5.62 | 151.3 | 26.9% | +545% |
| TECH | Bio-Techne Corporation | 8.64 | 44.6 | 5.2% | +893% |
| NBIX | Neurocrine Biosciences, Inc. | 11.69 | 22.7 | 1.9% | +1243% |